<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Neomycin Sulfate for Prescription Compounding; Withdrawal of Approval of One Abbreviated New Drug Application</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Neomycin Sulfate for Prescription Compounding; Withdrawal of Approval of One Abbreviated New Drug Application</h1>
    <p class="timestamp">Published: 2019-02-05 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is withdrawing approval of abbreviated new drug application (ANDA) 061579 for nonsterile neomycin sulfate powder for prescription compounding. The basis for the withdrawal is that the product is no longer considered safe as labeled due to clinical evidence that systemic exposure to neomycin sulfate can induce significant toxicity, including ototoxicity (manifested as sensorineural hearing loss), nephrotoxicity, and neuromuscular blockade. The hold...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-01131</p>
    <p><strong>Publication Date:</strong> 2019-02-05</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/02/05/2019-01131/neomycin-sulfate-for-prescription-compounding-withdrawal-of-approval-of-one-abbreviated-new-drug">https://www.federalregister.gov/documents/2019/02/05/2019-01131/neomycin-sulfate-for-prescription-compounding-withdrawal-of-approval-of-one-abbreviated-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-01131</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
